GH logo

GH
Guardant Health Inc

4,928
Mkt Cap
$13.59B
Volume
302,944.00
52W High
$120.74
52W Low
$34.88
PE Ratio
-32.69
GH Fundamentals
Price
$101.08
Prev Close
$105.03
Open
$105.68
50D MA
$106.41
Beta
1.41
Avg. Volume
2.01M
EPS (Annual)
-$3.56
P/B
-37.04
Rev/Employee
$365,668.48
$4,245.93
Loading...
Loading...
News
all
press releases
New York State Common Retirement Fund Has $4.77 Million Stake in Guardant Health, Inc. $GH
New York State Common Retirement Fund lowered its stake in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 27.2% in the third quarter, according to its most recent disclosure with the...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
IQ EQ FUND MANAGEMENT IRELAND Ltd Lowers Position in Guardant Health, Inc. $GH
IQ EQ FUND MANAGEMENT IRELAND Ltd cut its holdings in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 66.8% during the third quarter, according to the company in its most recent 13F filing with...
MarketBeat·4d ago
News Placeholder
Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Misses Revenue Estimates
Adaptive Biotechnologies (ADPT) delivered earnings and revenue surprises of +52.63% and -0.44%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·6d ago
News Placeholder
Guardant Health to Participate in Upcoming Investor Conferences
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences. BTIG 13th Annual MedTech, Digital...
Business Wire·8d ago
News Placeholder
Knights of Columbus Asset Advisors LLC Takes Position in Guardant Health, Inc. $GH
Knights of Columbus Asset Advisors LLC purchased a new stake in Guardant Health, Inc. (NASDAQ:GH - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and...
MarketBeat·10d ago
News Placeholder
Should You Buy Guardant Health Before Feb. 19?
Key PointsGuardant Health hasn't scheduled its Q4 update yet but will likely report results by Feb. 19, 2026...
Nasdaq News: Markets·12d ago
News Placeholder
Guardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the fourth quarter and full year 2025 after market close on Thursday...
Business Wire·13d ago
News Placeholder
Guardant Health, Inc. $GH Shares Bought by Federated Hermes Inc.
Federated Hermes Inc. grew its stake in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 21.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·13d ago
News Placeholder
Y Intercept Hong Kong Ltd Has $4.77 Million Holdings in Guardant Health, Inc. $GH
Y Intercept Hong Kong Ltd boosted its stake in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 66.7% in the third quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·16d ago
News Placeholder
Insider Selling: Guardant Health (NASDAQ:GH) Insider Sells 8,571 Shares of Stock
Guardant Health, Inc. (NASDAQ:GH - Get Free Report) insider Terilyn Monroe sold 8,571 shares of the business's stock in a transaction on Wednesday, January 21st. The stock was sold at an average...
MarketBeat·19d ago
<
1
2
...
>

Latest GH News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.